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Abstract
Background: Early detection of various types of nonmela-
noma skin cancer has been a challenge in dermatology. 
Noninvasive examination procedures such as optical coher-
ence tomography (OCT) play an increasingly important role, 
besides the established gold standard of histological tissue 
sample analysis. OCT is a noninvasive, cross-sectional, real-
time technique that allows conclusions to be drawn with 
regard to the presence of pathologies. Objective: The ob-
jective of this study was to investigate whether it is possible 
to distinguish between different types of nonmelanoma 
skin cancer using OCT or not. Methods: A study population 
of a total of 25 cases, comprising 5 cases, each, of 5 tumor 
entities (i.e., basal cell carcinoma, superficial basal cell carci-
noma, actinic keratosis, squamous cell carcinoma, and Bow-
en disease) was examined. Relevant lesions were scanned 
both centrally and peripherally in the multislice mode. All 
OCT images were blinded, randomized, analyzed, and eval-
uated by 2 clinicians experienced in OCT. Results: This study 
demonstrated that it is possible to determine correlations 
between various types of tumors and recurring tumor char-
acteristics. Conclusion: This study showed that it is possible 
to distinguish between the different nonmelanoma skin 
cancers by using OCT, but further prospective studies have 
to be conducted to validate the sensitivity and specificity of 
the criteria. © 2018 S. Karger AG, Basel
Introduction
A rapid increase in nonmelanoma skin cancer (NMSC) 
types has been observed in recent decades, especially af-
fecting individuals in the age group 60 years and over. 
Moreover, studies have shown that this trend is more 
common in men than in women. Time-consuming and 
cost-intensive sampling and histopathological processing 
and dyeing of the samples is the gold standard in diagno-
sis of the various NMSC types to date. However, recently, 
noninvasive optical diagnostic methods have increasing-
ly gained importance and show an increasing potential to 
complement the hitherto prevailing gold standard. For 
instance, procedures such as dermatoscopy, high-fre-
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py have already become established in the early detection 
of NMSC types [1–3]. Another equally promising proce-
dure that is increasingly gaining importance is optical co-
herence tomography (OCT). Like the above-mentioned 
procedures, OCT is an easily applied, noninvasive, real-
time technique that is based on low-coherence interfer-
ometry [4]. OCT was first practically described by Huang 
et al. [5] in 1991. Since then, it has undergone a continu-
ous process of improvement and advancement along with 
an extended field of application.
Thus, OCT has become a firmly established examina-
tion tool in the special fields of dermatology and ophthal-
mology [6–8], and it has generally been tested and used 
in all medical fields. For instance, OCT is already used in 
gastroenterology to detect malignant lesions in the gas-
trointestinal tract as well as possible responses to the 
resulting cancer therapy [9–11]. Moreover, application 
possibilities of OCT regarding breast cancer have been 
investigated in gynecology [12, 13]. The application of 
OCT in the field of neurology is also highly interesting. In 
neurology, OCT can be used to observe the effects of in-
tracranial hypertension and allows detection of the activ-
ity of demyelinating diseases even before neurological 
symptoms become apparent [14, 15].
Dermatology is another special field where OCT and its 
application have been under investigation for a long time. 
OCT itself and the requirements of OCT have continu-
ously changed from the first examinations of human skin 
in 1997 to studies dealing with more complex topics such 
as the applicability of OCT in wound healing or the defini-
tion of surgical resection limits [4, 16, 17]. However, the 
greatest and most sophisticated challenge is to investigate 
the applicability of OCT in NMSC diagnosis. Several stud-
ies have already been dedicated to the topic of creating 
standard detection criteria for the different NMSC types 
[2, 18–23]. Such standard criteria have successfully been 
defined for actinic keratosis (AK) as well as basal cell car-
cinoma (BCC), but they have turned out to be rather dif-
ficult to determine for the other tumor entities. In this 
study, we aimed to show correlations between detection 
criteria and the different NMSC types by means of OCT.
Materials and Methods
Participants
A total of 35 patients (16 males and 19 females) with a large 
variety of nonmelanoma tumor entities and lesions were examined 
using OCT in the period between June 2012 and February 2013, 
and the results of those examinations were acquired for our study. 
All of the participants were informed in detail about their inclusion 
into this study and the general conditions of this study prior to the 
examination and gave their written consent. This study was ap-
proved by the ethics committee of the Charité – Universitätsmed-
izin Berlin (EA1/061/09). All scientific research and examinations 
were performed in compliance with the principles of the Declara-
tion of Helsinki. At the time of the measurements, all participating 
patients had already been scheduled for verification by biopsy or 
surgical excision of their lesion. All examinations, measurements, 
and histopathological evaluations were performed at the Depart-
ment of Dermatology, Venerology and Allergology of the Chari- 
té – Universitätsmedizin Berlin.
After the initial evaluation of the histopathological results and 
quality assessment of the OCT-specific images, the patient popula-
tion of this study was reduced by 10 cases because images did not 
fulfill the quality criteria or histological results of the sample biop-
sies did not correspond to the tumor entities included in this study. 
Hence, 25 patients (15 males and 10 females) with a mean age of 
69 years (range 32–88) were finally included and evaluated in this 
study. All examined lesions of the participants in this study were 
scanned both centrally and peripherally in the OCT multislice 
mode. Unaffected skin on the contralateral side was also scanned 
for reference. 
OCT Device
OCT is a noninvasive, cross-sectional, real-time technique 
based on Michelson interferometry that is used to examine all 
kinds of benign and malignant skin diseases [18]. The lateral opti-
cal resolution is approximately 7.5 µm and the axial resolution is 
approximately < 10 µm. The scan covers an area of 6 × 6 mm2 at a 
maximum depth of 2 mm. Moreover, the examiner can choose be-
tween various acquisition modes such as, for example, the free run 
mode and the multislice mode. In the free run mode, the scan is 
only performed along the x axis, thus allowing free movability of 
the scan head. This is of special advantage if several regions are 
searched for potential lesions. By contrast, in the multislice mode, 
an entire series of images is acquired. Each area covered with this 
mode measures 6 × 6 mm2 and represents 1 image. The individual 
images are scanned at increments of 0.1 mm along the y axis [4]. 
This mode is primarily selected to visualize the transition between 
tumor-free skin and tumor. All examinations were performed with 
the OCT scanner type Vivosight of Michelson Diagnostics (Kent, 
UK). All measurements regarding the various tumor entities were 
exclusively performed in the multislice mode.
Imaging Procedure
The actual examination was performed by means of a multibeam 
OCT scanner after the participants had given their written informed 
consent. The affected skin regions were not specifically prepared for 
the measurements. Very hairy areas (e.g., the back part of the head, 
the arms, and the abdomen) were shaved to prevent potential inter-
ference and achieve an undisturbed deep penetration. The patients 
were asked to lie down flat on their back on the examination table 
throughout the procedure. The examination was performed using 
standard OCT settings. Thus, a high quality of measurements was 
achieved and a high reproducibility was ensured. Each patient un-
derwent 3 measurements in the multislice mode, each consisting of 
a series of 60 consecutive individual frames. The first measurement 
was always performed peripherally at the transition from unaffected 
skin towards the lesion. Then, the center of the lesion was scanned 
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erence scan of healthy skin on the contralateral side of the body was 
performed. This reference scan allowed differentiation between the 
characteristics of healthy and tumorous skin because healthy skin is 
exposed to all kinds of noxae over the years such as light and chem-
ical substances as well as plain skin aging and, therefore, may also 
show pathologies. After the examination, all of the participants re-
ceived their specific, previously planned therapy.
Statistics
Microsoft Office Excel 2007 was used to compile the data for the 
statistical analysis. The statistical data analysis was performed by 
means of SPSS 22 (SPSS Inc., Chicago, IL, USA). The normality of 
the age-specific distribution of the patient population was verified 
and confirmed beforehand with the Kolmogorov-Smirnov test. The 
actual statistical analysis of the 5 individual tumor criteria in relation 
to the 5 relevant tumor entities was performed by means of the Χ2 
test. The absolute presence of various criteria in the individual tu-
mor entities was determined based on purely descriptive analysis. 
After the statistical analysis, all results with a positive or negative 
Pearson ϕ coefficient and a p value < 0.05 were rated as significant. 
Moreover, trends were determined within the range 0.005 < p ≤ 0.1.
Development of Detection Criteria
In view of the fact that the incidence of NMSC types has con-
tinuously increased in the past decades, several studies have al-
ready been performed to investigate the applicability of OCT and 
early detection of these diseases by means of OCT and create stan-
dard detection criteria [1, 2, 18–22, 24, 25]. In the so-called “Berlin 
Score,” for instance, the focus was primarily placed on recurring 
OCT characteristics of BCC and their subtypes to investigate a pos-
sible correlation and its practical application to, and usefulness in, 
clinical routine [18]. In this study, similar characteristics were used 
as in previous studies [18] with regard to 5 different tumor entities, 
i.e., BCC, sBCC, AK, Bowen disease, and squamous cell carcinoma 
(SCC), to investigate any existing correlations. All characteristics 
were established based on clinical OCT experience and in close 
cooperation with dermatologists, students, and histopathologists. 
Other criteria such as parakeratosis, acanthosis, and occurrence of 
hyperreflective nests were analyzed besides the criteria established 
in the Berlin Score (e.g., noncompressible dark borders, ovoid 
structures, and hyporeflective nests) [18]. Similar to the Berlin 
Score all subtypes of BCC were included (e.g., nodular, micronod-
ular, cystic BCC, etc.). A total of 25 cases corresponding to 5 cases 
Fig. 1. Patient with medically normal skin. Different sections display the layers of normal skin (i.e., 1.1, epidermis; 
1.2, dermis; and 1.3, subcutis). The arrows indicate hair follicles.
Fig. 2. Patient with histologically verified squamous cell carcinoma and well-defined continuous parakeratosis. 

























   
   
   
   
   



















Nonmelanoma Skin Cancer 241Skin Pharmacol Physiol 2018;31:238–245
DOI: 10.1159/000489269
per tumor entity were blinded, randomized, and passed on to a 
team of 2 analysts experienced in OCT (a dermatologist and a hu-
man medicine student) for evaluation. A purely descriptive analy-
sis dealt only with the presence or absence of predefined criteria, 
where the score 0 was assigned to absence and 1 to presence. After 
the evaluation was completed, all OCT images were assigned to the 
relevant patient data and histologies (Fig. 1–8; Table 1).
Results
The results were evaluated based on a population of 
25 patients (15 males and 10 females). The ensuing Kol-
mogorov-Smirnov test showed normality of the age-spe-
cific distribution. The mean patient age was 69 years. The 
Χ2 test performed in relation to the gender-specific occur-
rence of tumor characteristics in the individual entities 
did not reveal any significant difference between the sexes. 
The followings results were obtained for the individual 
characteristics in relation to the different tumor entities.
The occurrence of the specific characteristic parakera-
tosis was negatively associated with the tumor entity BCC 
(ϕ = –0.579, p = 0.004).
BCC was also negatively associated with the character-
istic generalized acanthosis (ϕ = –0.750, p < 0.001).
The results obtained for focal acanthosis with the tu-
mor entity sBCC were different; a significantly positive 
association was found (ϕ = 0.500, p = 0.012).
The characteristic multifocal acanthosis showed a sig-
nificantly positive correlation with SCC (ϕ = 0.408, p = 
0.041) and Bowen disease (ϕ = 0.408, p = 0.041). By con-
trast, a negative significance was found regarding BCC 
(ϕ = –0.612, p = 0.002) and sBCC (ϕ = –0.408, p = 0.04).
Trends related to the characteristics were also shown 
with the Χ2 test. For instance, a negative trend was found 
Fig. 3. Patient with histologically verified Bowen disease and a thickened spinous layer (marked by the arrows).
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Fig. 7. Patient with histological verified superficial basal cell carcinoma. The arrows indicate tumor starting from 
the epidermis with minor hyperkeratosis.
Fig. 5. Another patient with histologically verified basal cell carcinoma and a noncompressible dark border be-
neath the tumor (indicated by the arrows).
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for the criterion hyporeflective nests in relation to the tu-
mor entities Bowen disease (ϕ = –0.343, p = 0.086) and 
AK (ϕ = –0.343, p = 0.086). By contrast, the presence of 
ovoid, hyporeflective nests was significantly positively 
correlated with the tumor entity BCC (ϕ = 0.729, p < 
0.001).
The criterion hyperreflective nests showed a signifi-
cantly positive association with SCC (ϕ = 0.590, p = 0.003). 
Noncompressible dark border, the last recurring crite-
rion analyzed, was significantly positively correlated with 
sBCC (ϕ = 0.458, p = 0.022) and BCC (ϕ = 0.667, p = 
0.001) and showed negative trends regarding the other 3 
tumor entities, i.e., SCC (ϕ = –0.375, p = 0.061), Bowen 
disease (ϕ = –0.375, p = 0.061), and AK (ϕ = 0.375, p = 
0.061; Table 2).
Discussion
OCT allows unambiguous differentiation between be-
nign and malignant skin lesions already at an early stage. 
However, distinguishing between individual tumor enti-
Fig. 8. Patient with histological verified actinic keratosis. The arrows indicate parakeratosis and hyperkeratosis 
of the upper skin layers (+) and acanthosis of the epidermis (Δ).
Table 1. Association of the established detection criteria with the different skin layers
Epidermis Dermis Subcutis
Parakeratosis Cornification disorder starting  
at the stratum corneum, visible  
as a thickened cell bulk
Acanthosis
(focal/multifocal)
Broadened stratum spinosum  
with acanthoid branches into 




Dark and inhomogeneous areas 
mostly located in the upper 
dermis; correlates to variable 
stroma and cell aggregates
Hyperreflective
nests
Homogeneous ovoid structures, 
surrounded by stroma with  




Localized from the dermis 
to subcutis under tumor nests; due 
to its noncompressible character 
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ties is still problematic [18, 24, 26, 27]. In this purely de-
scriptive study, it was shown that almost all tumor entities 
have recurring characteristics that might allow differen-
tiation by means of OCT in the future. Correlation and 
discrimination of the individual tumor entities based on 
signal intensity and layer thickness as described in former 
studies were not included in this study [28]. 
The so-called trends are also a factor that should not 
be neglected. They might play a significant role in larger 
study populations with greater numbers of cases and also 
possibly contribute to improved differentiation between 
the individual types of tumors.
However, there are also disadvantages with regard to 
OCT and its evaluability in this study. For instance, the 
applicability of OCT is limited to body regions where an 
adequate contact area between the scan unit and the skin 
surface is ensured. This makes OCT more difficult to use 
on acra or bony structures of the body. Moreover, the ex-
aminer’s experience in handling OCT and his/her ana-
lytical skills influence the achieved image quality and the 
results of the evaluation of the obtained image material 
and present a source of error that should not be underes-
timated. It is mandatory in the evaluation of OCT images 
to include healthy skin of the contralateral side for refer-
ence because even healthy skin is exposed to natural ag-
ing, noxae, and the sun, thus causing pathologies and 
leading to misinterpretation.
Time-consuming and cost-intensive sampling, histo-
pathological processing, and evaluation of the samples is 
still the gold standard for the early detection of the vari-
ous NMSC types to date. To date, it is not yet possible to 
use OCT as the only tool in early detection of NMSC types 
because of technical limitations. However, like other non-
invasive real-time techniques, OCT promises the possi-
bility of a fast, easy, cost-effective, and painless means 
to replace the existing standard in the future. This as-
sumption is especially encouraged by the latest develop-
ments such as HD-OCT (high-definition OCT) and SV-
OCT (speckle-variance OCT) as well as D-OCT (dynam-
ic OCT) [29–34]. D-OCT, a naval angiographic variant of 
OCT, for example, may aid in distinguishing between the 
different tumor entities because of its particular vascular 
morphology. This was already demonstrated using the 
example of AK, Bowen disease, and SCC [34]. In the con-
text of further studies, the already established differentia-
tion criteria could be complemented.
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BCC – – (+)
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Bowen disease + (–) –
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AK, actinic keratosis; BCC, basal cell carcinoma; sBCC, superficial basal cell carcinoma; SCC, squamous cell carcinoma; +, positive 
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